These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31146627)

  • 21. The Impact of the Share 35 Policy on Racial and Ethnic Disparities in Access to Liver Transplantation for Patients with End Stage Liver Disease in the United States: An Analysis from UNOS Database.
    Zhang Y
    Int J Equity Health; 2017 Mar; 16(1):55. PubMed ID: 28340592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretransplant Sarcopenia in Patients With NASH Cirrhosis Does Not Impact Rehospitalization or Mortality.
    Aby ES; Lee E; Saggi SS; Viramontes MR; Grotts JF; Agopian VG; Busuttil RW; Saab S
    J Clin Gastroenterol; 2019 Oct; 53(9):680-685. PubMed ID: 30180152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethnic disparities in waitlist outcomes of patients with nonalcoholic steatohepatitis listed for liver transplantation in the US.
    Lim WH; Yong JN; Ong CEY; Ng CH; Tan DJH; Zeng RW; Chung CH; Kaewdech A; Chee D; Tseng M; Wijarnpreecha K; Syn N; Bonney GK; Kow A; Huang DQ; Noureddin M; Muthiah M; Tan E; Siddiqui MS
    Liver Transpl; 2023 Nov; 29(11):1181-1191. PubMed ID: 37039547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study.
    Haldar D; Kern B; Hodson J; Armstrong MJ; Adam R; Berlakovich G; Fritz J; Feurstein B; Popp W; Karam V; Muiesan P; O'Grady J; Jamieson N; Wigmore SJ; Pirenne J; Malek-Hosseini SA; Hidalgo E; Tokat Y; Paul A; Pratschke J; Bartels M; Trunecka P; Settmacher U; Pinzani M; Duvoux C; Newsome PN; Schneeberger S;
    J Hepatol; 2019 Aug; 71(2):313-322. PubMed ID: 31071367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in Characteristics of Patients Listed for Liver Transplantation Will Lead to Higher Rates of Waitlist Removal Due to Clinical Deterioration.
    Yi Z; Mayorga ME; Orman ES; Wheeler SB; Hayashi PH; Barritt AS
    Transplantation; 2017 Oct; 101(10):2368-2374. PubMed ID: 28858174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National Outcomes of Liver Transplantation for Model for End-Stage Liver Disease Score ≥40: The Impact of Share 35.
    Nekrasov V; Matsuoka L; Rauf M; Kaur N; Cao S; Groshen S; Alexopoulos SP
    Am J Transplant; 2016 Oct; 16(10):2912-2924. PubMed ID: 27063579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First Look: One Year Since Inception of Regional Share 35 Policy.
    Annamalai A; Ayoub W; Sundaram V; Klein A
    Transplant Proc; 2015; 47(6):1585-90. PubMed ID: 26293017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver Transplantation in France.
    Durand F; Antoine C; Soubrane O
    Liver Transpl; 2019 May; 25(5):763-770. PubMed ID: 30697904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
    Salvalaggio PR; Afonso RC; Pereira LA; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation.
    Volk ML; Lok AS; Pelletier SJ; Ubel PA; Hayward RA
    Gastroenterology; 2008 Nov; 135(5):1568-74. PubMed ID: 19009713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aging of Liver Transplant Registrants and Recipients: Trends and Impact on Waitlist Outcomes, Post-Transplantation Outcomes, and Transplant-Related Survival Benefit.
    Su F; Yu L; Berry K; Liou IW; Landis CS; Rayhill SC; Reyes JD; Ioannou GN
    Gastroenterology; 2016 Feb; 150(2):441-53.e6; quiz e16. PubMed ID: 26522262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of broader regional sharing of livers: 2-year results of "Share 35".
    Edwards EB; Harper AM; Hirose R; Mulligan DC
    Liver Transpl; 2016 Apr; 22(4):399-409. PubMed ID: 26890858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared With Cryptogenic, Alcoholic, or AIH Cirrhosis.
    Thuluvath PJ; Hanish S; Savva Y
    Transplantation; 2019 Jan; 103(1):113-121. PubMed ID: 29985186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing prevalence of nonalcoholic steatohepatitis as an indication for liver transplantation.
    Quillin RC; Wilson GC; Sutton JM; Hanseman DJ; Paterno F; Cuffy MC; Paquette IM; Diwan TS; Woodle ES; Abbott DE; Shah SA
    Surgery; 2014 Oct; 156(4):1049-56. PubMed ID: 25239365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: Data from the United States Scientific Registry of Transplant Recipients.
    Stepanova M; Kabbara K; Mohess D; Verma M; Roche-Green A; AlQahtani S; Ong J; Burra P; Younossi ZM
    Hepatol Commun; 2022 Jul; 6(7):1506-1515. PubMed ID: 35224886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver transplantation after share 35: Impact on pretransplant and posttransplant costs and mortality.
    Nicolas CT; Nyberg SL; Heimbach JK; Watt K; Chen HS; Hathcock MA; Kremers WK
    Liver Transpl; 2017 Jan; 23(1):11-18. PubMed ID: 27658200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perioperative mortality in liver transplantation before and after the implementation of the organ allocation policy Share 35.
    Holm ZD; Kolodzie K; Galli AM; Meyhoff CS; Niemann CU; Adelmann D
    Clin Transplant; 2023 Jan; 37(1):e14854. PubMed ID: 36380529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of rapid Model for End-Stage Liver Disease (MELD) increases for liver transplant registrant prioritization after MELD-Na and Share 35, an evaluation using data from the United Network for Organ Sharing.
    Brock GN; Washburn K; Marvin MR
    PLoS One; 2019; 14(10):e0223053. PubMed ID: 31581270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver transplantation for nonalcoholic steatohepatitis in young patients.
    Alkhouri N; Hanouneh IA; Zein NN; Lopez R; Kelly D; Eghtesad B; Fung JJ
    Transpl Int; 2016 Apr; 29(4):418-24. PubMed ID: 26402655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.
    Younossi ZM; Marchesini G; Pinto-Cortez H; Petta S
    Transplantation; 2019 Jan; 103(1):22-27. PubMed ID: 30335697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.